Buy, Hold, or Wait: 3 Small-Cap Stocks Telling Different Stories

The Russell 2000 small-cap index has risen about 18% in 2026, roughly double the S&P 500, as investors rotate away from pricey technology stocks.

Boston Beer remains a Hold after lowering its 2026 earnings guidance and trading at an eight-year low, though analysts see over 20% upside ahead of its July 23 earnings report.

Opera Limited is rated a Buy due to strong AI-driven revenue growth, undervalued financials, a dividend yield above 4%, and a $300 million buyback plan, while Lindblad Expeditions looks attractive long term but extended in the short term.

As of July 20, the Russell 2000 index, often referred to as the small-cap index, is up approximately 18% in 2026. That’s about double the gains of the S&P 500 and evidence of the sector rotation in the market.

The idea is that many investors who are looking for alternatives to technology stocks and their frothy valuations are turning to small-cap stocks that have sold off sharply.

It’s not exactly a growth-versus-value play. Small-cap stocks often lag the market for good reasons. In many cases, the companies are not profitable and may have little revenue. But that’s not always the case, which is where the opportunity may lie.

Investors are looking for options, and they may find them in small-cap stocks. But as with any group of stocks, it’s important to know what you’re buying. Here are three small-cap stocks at different stages, each with an impact on the short-term investment outlook.

Boston Beer Today SAM Boston Beer $180.43 +1.63 (+0.91%) As of 07/20/2026 03:59 PM Eastern This is a fair market value price provided by Massive. Learn more. 52-Week Range $158.68 ▼ $264.46 Price Target $224.00 Add to Watchlist Alcohol stocks face several headwinds, including shifting consumer tastes, GLP-1 drugs, and an overall trend toward health and wellness.

Boston Beer NYSE: SAM , known for its signature Samuel Adams brand of craft beer, has seen better days.

SAM is down over 80% in the last five years and is trading at an eight-year low. Short interest at around 24% doesn’t help.

This isn’t a balance sheet story; it’s about earnings. In Q1 2026, the company lowered its adjusted earnings per share (EPS) guidance to a range between $8.50 and $10.50.

At the midpoint, it would be on par with the company’s EPS for all of 2025.

The company’s founder, Jim Koch, returned as chief executive officer (CEO) in Aug. 2025. However, that hasn’t done much for SAM in the short term.

It’s still early days, however. The consensus analyst price target is approximately $224 , which would be more than 20% above its July 20 price.

That aside, the stock has a consensus rating of Reduce, but that could change with the company’s earnings report due on July 23.

Opera Today OPRA Opera $19.58 +0.22 (+1.14%) As of 07/20/2026 04:00 PM Eastern 52-Week Range $11.71 ▼ $21.06 Dividend Yield 3.98% P/E Ratio 15.54 Price Target $21.50 Add to Watchlist Opera Limited NASDAQ: OPRA is best known for its Opera web browser.

But the reason for the stock’s return of about 92% in the last five years is the company’s pivot into agentic artificial intelligence (AI).

The contrast with a company like Boston Beer is a story that’s played out in the broader market.

Investor capital has moved from consumer goods to technology, and specifically AI.

But is there enough upside left?

Analysts give OPRA a consensus price target of $21.50 , about 10% higher than its price on July 20.

The company is also forecasting full-year revenue between $720 million and $735 million.

At the low end, that’s a 25% year-over-year increase, suggesting the consensus target may be too low.

Complicating the o...